| pegylated liposomal doxorubicin / Generic mfg. |
NCT00003334: Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract |
|
|
| Completed | 2 | | US | paclitaxel, pegylated liposomal doxorubicin hydrochloride | NYU Langone Health, National Cancer Institute (NCI) | Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma | 12/01 | | | |
NCT00216645: Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy |
|
|
| Completed | 2 | 74 | Japan | doxorubicin hydrochloride | Janssen Pharmaceutical K.K. | Ovarian Neoplasms | | 11/06 | | |
NCT00003896: S9912 Combination Chemo in Stage III Ovarian Cancer, |
|
|
| Completed | 2 | 68 | US | cisplatin, platinol, liposomal doxorubicin, pegylated liposomal doxorubicin hydrochloride, doxil, paclitaxel, taxol | Southwest Oncology Group, National Cancer Institute (NCI) | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 02/08 | 02/08 | | |
NCT00653328: Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma |
|
|
| Terminated | 2 | 15 | US | atrasentan hydrochloride, ABT-627, Xinlay, doxil, pegylated liposomal doxorubicin hydrochloride (Doxil) | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 03/09 | 03/09 | | |
NCT00698451: A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers |
|
|
| Completed | 2 | 54 | US | doxorubicin HCL liposome; bevacizumab; carboplatin | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Centocor Ortho Biotech Services, L.L.C. | Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms | 10/10 | 10/10 | | |
|
NCT00032162: Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer |
|
|
| Completed | 1/2 | 63 | Europe | carboplatin, pegylated liposomal doxorubicin hydrochloride | AGO Study Group | Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma | 05/05 | | | |
NCT00903630: Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer |
|
|
| Terminated | 1/2 | 15 | US | Lenalidomide, Revlimid, liposomal doxorubicin, Caelyx® | Masonic Cancer Center, University of Minnesota, Celgene Corporation | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 08/11 | 08/11 | | |
NCT00182767: Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer |
|
|
| Completed | 1/2 | 45 | US | ixabepilone, BMS-247550, epothilone B lactam, Ixempra, pegylated liposomal doxorubicin hydrochloride, CAELYX, Dox-SL, DOXIL, doxorubicin hydrochloride liposome, LipoDox | National Cancer Institute (NCI) | Fallopian Tube Cancer, Female Reproductive Cancer, Recurrent Breast Cancer, Recurrent Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Breast Cancer, Stage IV Ovarian Epithelial Cancer | 04/12 | 05/14 | | |
